Tysabri failure in stroke a setback for Biogen
Stroke is a major cause of disability and death worldwide and the third most common cause of death in developed countries. Nearly six million people die from stroke every year and another five million are left permanently disabled.
Neuravi’s Embotrap II can clear blood clots responsible for stroke.
MindMotion Pro helps with upper-limb rehabilitation following a stroke.
Acquisition provides Biogen a fall back molecule in this high risk therapy area.
Five-year deal aims to reduce misdiagnosis of brain bleeds caused by trauma or stroke.
NeuroEyeCoach helps users re-train their eye movement to better compensate for visual field loss.
Combined app will give patients a more complete view of their heart health.